TABLE OF CONTENTS
1 INTRODUCTION 36
1.1 OBJECTIVES OF THE STUDY 36
1.2 MARKET DEFINITION 36
1.3 OVERVIEW OF THE ASIA-PACIFIC RADIOTHERAPY MARKET 36
1.4 CURRENCY AND PRICING 38
1.5 LIMITATIONS 38
1.6 MARKETS COVERED 38
2 MARKET SEGMENTATION 41
2.1 MARKETS COVERED 41
2.2 GEOGRAPHICAL SCOPE 42
2.3 YEARS CONSIDERED FOR THE STUDY 43
2.4 DBMR TRIPOD DATA VALIDATION MODEL 44
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 47
2.6 MULTIVARIATE MODELLING 48
2.7 PRODUCT AND SERVICES SEGMENT LIFELINE CURVE 49
2.8 MARKET END USERS COVERAGE GRID 50
2.9 DBMR MARKET POSITION GRID 51
2.10 VENDOR SHARE ANALYSIS 52
2.11 SECONDARY SOURCES 53
2.12 ASSUMPTIONS 53
3 EXECUTIVE SUMMARY 54
4 PREMIUM INSIGHTS 56
4.1 PESTLE ANALYSIS 57
4.2 PORTER’S FIVE FORCES MODEL 58
4.3 PRICING ANALYSIS 59
5 REGULATORY GUIDELINES FOR RADIOTHERAPY 61
6 MARKET OVERVIEW 64
6.1 DRIVERS 66
6.1.1 GROWING PREVALENCE OF CANCER DISEASE 66
6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT 66
6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES 67
6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES 67
6.2 RESTRAINTS 67
6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 67
6.2.2 HIGH COST OF TREATMENT AND RADIOTHERAPY PROCEDURE 68
6.3 OPPORTUNITIES 68
6.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER TREATMENT 68
6.3.2 GROWING GOVERNMENT INITIATIVES TOWARD CANCER TREATMENT 69
6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT 70
6.4 CHALLENGES 70
6.4.1 STRICT REGULATIONS AND STANDARDS FOR APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS 70
6.4.2 RISK OF RADIATION EXPOSURE 71
7 ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT & SERVICES 72
7.1 OVERVIEW 73
7.2 SERVICES 75
7.3 PRODUCT 75
7.4 SOFTWARE 75
8 ASIA-PACIFIC RADIOTHERAPY MARKET, BY TYPE 76
8.1 OVERVIEW 77
8.2 EXTERNAL-BEAM RADIATION THERAPY 79
8.3 INTERNAL RADIATION THERAPY 79
8.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS 79
8.5 OTHERS 79
9 ASIA-PACIFIC RADIOTHERAPY MARKET, BY APPLICATION 80
3.1 OVERVIEW 81
9.1 BREAST CANCER 84
9.2 LUNG CANCER 84
9.3 PROSTATE CANCER 84
9.4 COLORECTAL CANCER 84
9.5 LYMPHOMA 84
9.6 LIVER CANCER 84
9.7 THYROID CANCER 84
9.8 BRAIN CANCER 84
9.9 CERVICAL CANCER 85
9.10 SPINE CANCER 85
9.11 OTHERS 85
10 ASIA-PACIFIC RADIOTHERAPY MARKET, BY END USER 86
10.1 OVERVIEW 87
10.2 HOSPITALS 89
10.3 RADIATION THERAPY CENTERS 89
10.4 SPECIALTY CLINICS 89
10.5 OTHERS 89
11 ASIA-PACIFIC RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL 90
11.1 OVERVIEW 91
11.2 DIRECT TENDERS 93
11.3 THIRD PARTY DISTRIBUTORS 93
11.4 OTHERS 93
12 ASIA-PACIFIC RADIOTHERAPY MARKET, BY REGION 94
12.1 ASIA-PACIFIC 95
12.2 CHINA 162
13 ASIA-PACIFIC RADIOTHERAPY MARKET: COMPANY LANDSCAPE 168
13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 168
14 SWOT ANALYSIS 169
15 COMPANY PROFILE 170
15.1 SIEMENS HEALTHCARE GMBH 170
15.1.1 COMPANY SNAPSHOT 170
15.1.2 REVENUE ANALYSIS 170
15.1.3 COMPANY SHARE ANALYSIS 171
15.1.4 PRODUCT PORTFOLIO 171
15.1.5 RECENT DEVELOPMENT 171
15.2 ELEKTA 172
15.2.1 COMPANY SNAPSHOT 172
15.2.2 REVENUE ANALYSIS 172
15.2.3 COMPANY SHARE ANALYSIS 173
15.2.4 PRODUCT PORTFOLIO 173
15.2.5 RECENT DEVELOPMENTS 173
15.3 GENERAL ELECTRIC COMPANY 174
15.3.1 COMPANY SNAPSHOT 174
15.3.2 REVENUE ANALYSIS 174
15.3.3 COMPANY SHARE ANALYSIS 175
15.3.4 PRODUCT PORTFOLIO 175
15.3.5 RECENT DEVELOPMENT 175
15.4 HITACHI, LTD. 176
15.4.1 COMPANY SNAPSHOT 176
15.4.2 REVENUE ANALYSIS 176
15.4.3 PRODUCT PORTFOLIO 177
15.4.4 RECENT DEVELOPMENT 177
15.5 KONINKLIJKE PHILIPS N.V. 178
15.5.1 COMPANY SNAPSHOT 178
15.5.2 REVENUE ANALYSIS 178
15.5.3 COMPANY SHARE ANALYSIS 179
15.5.4 PRODUCT PORTFOLIO 179
15.5.5 RECENT DEVELOPMENT 179
15.6 ACCURACY INCORPORATED 180
15.6.1 COMPANY SNAPSHOT 180
15.6.2 REVENUE ANALYSIS 180
15.6.3 PRODUCT PORTFOLIO 181
15.6.4 RECENT DEVELOPMENT 181
15.7 BEBIG MEDICAL. 182
15.7.1 COMPANY SNAPSHOT 182
15.7.2 PRODUCT PORTFOLIO 182
15.7.3 RECENT DEVELOPMENT 182
15.8 BRAINLAB AG 183
15.8.1 COMPANY SNAPSHOT 183
15.8.2 PRODUCT PORTFOLIO 183
15.8.3 RECENT DEVELOPMENTS 183
15.9 CANON MEDICAL SYSTEMS CORPORATION 184
15.9.1 COMPANY SNAPSHOT 184
15.9.2 REVENUE ANALYSIS 184
15.9.3 PRODUCT PORTFOLIO 185
15.9.4 RECENT DEVELOPMENT 185
15.10 ECKERT & ZIEGLER BEBIG 186
15.10.1 COMPANY SNAPSHOT 186
15.10.2 REVENUE ANALYSIS 186
15.10.3 PRODUCT PORTFOLIO 187
15.10.4 RECENT DEVELOPMENT 187
15.11 IBA WORLDWIDE 188
15.11.1 COMPANY SNAPSHOT 188
15.11.2 REVENUE ANALYSIS 188
15.11.3 PRODUCT PORTFOLIO 189
15.11.4 RECENT DEVELOPMENT 189
15.12 LINATECH INC 190
15.12.1 COMPANY SNAPSHOT 190
15.12.2 PRODUCT PORTFOLIO 190
15.12.3 RECENT DEVELOPMENT 190
15.13 MEVION MEDICAL SYSTEMS 191
15.13.1 COMPANY SNAPSHOT 191
15.13.2 PRODUCT PORTFOLIO 191
15.13.3 RECENT DEVELOPMENT 191
15.14 NORDION (CANADA) INC. (A SUBSIDIARY OF SOTERA HEALTH) 192
15.14.1 COMPANY SNAPSHOT 192
15.14.2 PRODUCT PORTFOLIO 192
15.14.3 RECENT DEVELOPMENT 192
15.15 P-CURE 193
15.15.1 COMPANY SNAPSHOT 193
15.15.2 PRODUCT PORTFOLIO 193
15.15.3 RECENT DEVELOPMENT 193
15.16 SHINVA MEDICAL INSTRUMENT CO., LTD. 194
15.16.1 COMPANY SNAPSHOT 194
15.16.2 PRODUCT PORTFOLIO 194
15.16.3 RECENT DEVELOPMENT 194
15.17 UNITED IMAGING HEALTHCARE CO., LTD 195
15.17.1 COMPANY SNAPSHOT 195
15.17.2 PRODUCT PORTFOLIO 195
15.17.3 RECENT DEVELOPMENT 195
15.18 VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”) 196
15.18.1 COMPANY SNAPSHOT 196
15.18.2 REVENUE ANALYSIS 196
15.18.3 PRODUCT PORTFOLIO 197
15.18.4 RECENT DEVELOPMENT 197
15.19 ZEISS INTERNATIONAL 198
15.19.1 COMPANY SNAPSHOT 198
15.19.2 REVENUE ANALYSIS 198
15.19.3 COMPANY SHARE ANALYSIS 199
15.19.4 PRODUCT PORTFOLIO 199
15.19.5 RECENT DEVELOPMENT 199
16 QUESTIONNAIRE 200
17 RELATED REPORTS 204
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
